Low impact
UK regulatory authority approves Eli Lilly's Mounjaro (tirzepatide) for weight management and type 2 diabetes treatment.
FirstSquawk08/10, 06:35 PM
Related assets
Coming up for LLY
Explore next
Latest LLY news
Jin1008/17, 07:48 PM
Bloomberg08/13, 05:57 PM
FirstSquawk08/13, 12:08 PM
Berenberg raises Eli Lilly price target to $1,220 from $1,135.